Single Dose Pharmacokinetics of Oral Tenofovir in Plasma, Peripheral Blood Mononuclear Cells, Colonic Tissue, and Vaginal Tissue

HIV seroconversion outcomes in preexposure prophylaxis (PrEP) trials of oral tenofovir (TFV)-containing regimens are highly sensitive to drug concentration, yet less-than-daily dosing regimens are under study. Description of TFV and its active moiety, TFV diphosphate (TFV-DP), in blood, vaginal tiss...

Full description

Bibliographic Details
Main Authors: Louissaint, Nicolette A., Cao, Ying-Jun, Skipper, Paul L., Liberman, Rosa G., Nimmagadda, Sridhar, Anderson, Jean R., Everts, Stephanie, Bakshi, Rahul, Fuchs, Edward J., Hendrix, Craig W., Tannenbaum, Steven Robert
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering
Format: Article
Language:en_US
Published: Mary Ann Liebert, Inc. 2015
Online Access:http://hdl.handle.net/1721.1/99519